Floseal

DEVICE12 trials

Sponsors

University of California, Irvine, Ottawa Hospital Research Institute, CHA University, Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal, Maisonneuve-Rosemont Hospital

Conditions

Blood LossCardiothoracic SurgeryCoronary Artery DiseaseEpistaxisGynecologic CancerHereditary Hemorrhagic Telangiectasia (HHT)Intraoperative BleedingKidney Calculi

Phase 3

Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix

CompletedNCT01857466

CHA UniversityOvarian Cysts

Start: 2012-12-31End: 2013-10-31Updated: 2014-06-25

Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer

Ewha Womans University Mokdong HospitalGynecologic Cancer

Start: 2013-12-31End: 2016-12-31Target: 40Updated: 2015-02-11

Phase 4

Study to Compare the Addition of Floseal to Our Standard of Care to Control Post Operative Bleeding in TKR

CompletedNCT01891461

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de MontrealIntraoperative Bleeding, Post-operative Bleeding

Start: 2012-01-31End: 2017-01-31Updated: 2017-08-09

Collagen-thrombin Matrix Efficacy During Cardiac Surgery: a Prospective Randomized Controlled Trial

CompletedNCT04310150

Yonsei UniversityCoronary Artery Disease

Start: 2018-02-05End: 2020-03-31Updated: 2022-03-21

Unknown Phase

FloSeal Tubeless Exit Versus Cope Loop Nephrostomy Versus Fascial Stitch Following Percutaneous Nephrolithotripsy

CompletedNCT00360477

University of California, IrvineKidney Calculi

Start: 2004-06-30End: 2015-01-31Updated: 2016-12-13

Floseal Treatment for Posterior Epistaxis Study

CompletedNCT01098578

Ottawa Hospital Research InstituteEpistaxis

Start: 2010-04-30End: 2011-11-30Updated: 2015-01-26

FloSeal in CRS and HIPEC

CompletedNCT01957852

Maisonneuve-Rosemont HospitalPeritoneal Carcinomatosis

Start: 2008-01-31End: 2013-04-30Updated: 2015-02-25

Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)

CompletedNCT02638012

Unity Health TorontoEpistaxis, Hereditary Hemorrhagic Telangiectasia (HHT)

Start: 2015-12-31End: 2019-12-31Updated: 2020-05-28

Randomized Assessment of Devices Used to Prevent Post-operative Hemorrhagic Risk in Endonasal Surgery

CompletedNCT03243344

Centre Hospitalier Universitaire de BesanconOtorhinolaryngologic Diseases

Start: 2010-03-31End: 2013-05-31Updated: 2017-08-09

Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations

CompletedNCT03725098

Biom'Up France SASCardiothoracic Surgery

Start: 2019-03-01End: 2019-06-28Updated: 2020-01-13

Hemostatic Agent Use and Intraoperative Blood Loss in Lumbar Spine Surgery

CompletedNCT04058665

Johns Hopkins UniversityBlood Loss

Start: 2019-06-18End: 2022-03-01Updated: 2023-04-14

Tract Closure in PCNL

RecruitingNCT07668817

Icahn School of Medicine at Mount SinaiNephrolithiasis

Start: 2026-07-01End: 2028-06-01Target: 92Updated: 2026-06-25

Related Papers

Hemostatic efficacy of a flowable collagen-thrombin matrix during coronary artery bypass grafting: a double-blind randomized controlled trial.

2023-06-154 citations

Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)

Journal of Otolaryngology - Head and Neck Surgery2019-01-0117 citations

Additional benefit of hemostatic sealant in preservation of ovarian reserve during laparoscopic ovarian cystectomy: a multi-center, randomized controlled trial

Human Reproduction2014-06-0457 citations

Prospective clinical trial of gelatin-thrombin matrix as first line treatment of posterior epistaxis.

2013-06-2820 citations